- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.11. | Camp4 Therapeutics GAAP EPS of -$24.19 | 1 | Seeking Alpha | ||
| CAMP4 THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 21.11. | CAMP4 Therapeutics: CAMP4 Reports Third Quarter 2024 Financial Results | 86 | GlobeNewswire (Europe) | - Completed Initial Public Offering (IPO) of common stock, raising gross proceeds of $82.1M- Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 completed; safety data anticipated... ► Artikel lesen | |
| 21.11. | Camp4 Therapeutics Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
| 21.11. | Camp4 Therapeutics Corp - 8-K, Current Report | - | SEC Filings | ||
| 05.11. | CAMP4 Analyst Highlights Rare Disease Platform Potential | 2 | Benzinga.com | ||
| 05.11. | Camp4 gains after earning bullish views on Street | 1 | Seeking Alpha | ||
| 05.11. | William Blair upbeat on CAMP4 shares with Outperform rating | 3 | Investing.com | ||
| 05.11. | Leerink sets stock target for CAMP4, cites broad UCD treatment potential | 1 | Investing.com | ||
| 05.11. | Piper Sandler optimistic on CAMP4 stock, cites potential in pioneering RNA technology | 1 | Investing.com | ||
| 05.11. | Piper Sandler optimistisch für CAMP4-Aktie, verweist auf Potenzial in bahnbrechender RNA-Technologie | 1 | Investing.com Deutsch | ||
| 05.11. | JPMorgan sees "breakthrough potential" in CAMP4 stock, bets big on RNA tech | 4 | Investing.com | ||
| 16.10. | Camp4 Therapeutics Corp - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 15.10. | Camp4 Therapeutics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 11.10. | CAMP4 stock edges up 2% following $75M IPO | 5 | Seeking Alpha | ||
| 11.10. | RNA biotech CAMP4 Therapeutics prices IPO below the range at $11; adds shares to keep deal size at $75 million | 2 | Renaissance Capital | ||
| 11.10. | CAMP4 Therapeutics prices $75MIPO at $11 per share | 1 | Seeking Alpha | ||
| 11.10. | CAMP4 Therapeutics Prices 6.82M Share IPO at $11/sh | 2 | Investing.com | ||
| 11.10. | Upstream swells IPO to $255M as it prepares to join Nasdaq along with CAMP4 | 1 | FierceBiotech | ||
| 11.10. | CAMP4 Therapeutics: CAMP4 Announces Pricing of Initial Public Offering | 137 | GlobeNewswire (Europe) |
CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting... ► Artikel lesen | |
| 08.10. | Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
CAMP4 THERAPEUTICS CORP gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 7,140 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAMP4 THERAPEUTICS CORP finden Sie auf Wallstreet Online.
